Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis

BACKGROUND: Localized Gleason Grade Group 5 (GG5) prostate cancer has a poor prognosis and is associated with a higher risk of treatment failure, metastases, and death. Treatment intensification with the addition of a brachytherapy (BT) boost to external beam radiation (EBRT) maximizes local control...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Terence, Gulstene, Stephanie, McArthur, Eric, Warner, Andrew, Boldt, Gabriel, Velker, Vikram, D'Souza, David, Bauman, Glenn, Mendez, Lucas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637706/
https://www.ncbi.nlm.nih.gov/pubmed/36353652
http://dx.doi.org/10.1016/j.ctro.2022.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637706/
https://www.ncbi.nlm.nih.gov/pubmed/36353652
http://dx.doi.org/10.1016/j.ctro.2022.10.010

Ejemplares similares